Amanote Research

Amanote Research

    RegisterSign In

First Fluoroquinolone to Treat MRSA Approved in Oral, I.V. Formulations

Pharmacy Today
doi 10.1016/j.ptdy.2017.08.015
Full Text
Open PDF
Abstract

Available in full text

Date

September 1, 2017

Authors
Cara Aldridge Young
Publisher

Elsevier BV


Related search

Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis

NeuroPharmac Journal
2019English

Possible FDA-approved Drugs to Treat Ebola Virus Infection

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2015English

New & Approved: New Approvals, Indications, Formulations

Pharmacy Today
2018English

Is First-Line Antimicrobial Therapy Still Adequate to Treat MRSA in the ICU? A Report From a Highly Endemic Country

Critical Care
Critical CareIntensive Care Medicine
2016English

Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection

Frontiers in Microbiology
Microbiology
2015English

FDA Approves First Biosimilar to Treat Cancer

Cancer Discovery
Oncology
2017English

Herbals and Its Marketed Formulations to Treat Diabetes Mellitus DM: An Overview

International Journal of Trend in Scientific Research and Development
2018English

Plasma-First Resuscitation to Treat Haemorrhagic Shock in Urban Areas

The Lancet
Medicine
2020English

Plasma-First Resuscitation to Treat Haemorrhagic Shock in Urban Areas

The Lancet
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy